Paperpal Prime Logo

Current Pharmaceutical Analysis : Impact Factor & More

eISSN: 1875-676XpISSN: 1573-4129

Key Metrics

CiteScore
1.2
Impact Factor
< 5
SJR
Q4Biophysics
SNIP
0.31
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Current Pharmaceutical Analysis

Current Pharmaceutical Analysis Journal Specifications

Overview
Publisher BENTHAM SCIENCE PUBL LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2005
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Current Pharmaceutical Analysis ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Current Pharmaceutical Analysis

Astragaloside IV Alleviates Peritoneal Dialysis-Related Peritoneal Fibrosis by Regulating HIF-1α-Mediated Autophagy
  • 1 Oct 2026
  • Current Pharmaceutical Analysis
Novel dichloroacetamide derivatives: Synthesis, cytotoxicity evaluation, molecular docking study, MD simulations, and ADME study
  • 1 Oct 2026
  • Current Pharmaceutical Analysis
A novel stability indicating LC method for simultaneous determination of Vildagliptin and Pioglitazone hydrochloride in API and marketed formulations
  • 1 Oct 2026
  • Current Pharmaceutical Analysis
Network pharmacology and molecular docking reveal the active compounds and key targets of JiaWei SiNi San in hepatocellular carcinoma
  • 1 Oct 2026
  • Current Pharmaceutical Analysis
Refining sedation strategies in elderly patients: A critical analysis of esketamine and propofol combination in gastrointestinal endoscopy
  • 1 Oct 2026
  • Current Pharmaceutical Analysis
Applications of QSPR polynomial and empirical models for predicting physicochemical properties of pharmaceutically important compounds
  • 1 Oct 2026
  • Current Pharmaceutical Analysis
Astragaloside IV Alleviates Peritoneal Dialysis-Related Peritoneal Fibrosis by Regulating HIF-1α-Mediated Autophagy
  • 1 Oct 2026
  • Current Pharmaceutical Analysis
Novel dichloroacetamide derivatives: Synthesis, cytotoxicity evaluation, molecular docking study, MD simulations, and ADME study
  • 1 Oct 2026
  • Current Pharmaceutical Analysis
A novel stability indicating LC method for simultaneous determination of Vildagliptin and Pioglitazone hydrochloride in API and marketed formulations
  • 1 Oct 2026
  • Current Pharmaceutical Analysis
Network pharmacology and molecular docking reveal the active compounds and key targets of JiaWei SiNi San in hepatocellular carcinoma
  • 1 Oct 2026
  • Current Pharmaceutical Analysis
Refining sedation strategies in elderly patients: A critical analysis of esketamine and propofol combination in gastrointestinal endoscopy
  • 1 Oct 2026
  • Current Pharmaceutical Analysis
Applications of QSPR polynomial and empirical models for predicting physicochemical properties of pharmaceutically important compounds
  • 1 Oct 2026
  • Current Pharmaceutical Analysis

FAQs on Current Pharmaceutical Analysis